Still riding the high of last…
Still riding the high of last year’s twice-yearly HIV PrEP [...]
The twisting journey of Pretzel…
The twisting journey of Pretzel Therapeutics’ top brass appears to [...]
The J.P. Morgan Healthcare…
The J.P. Morgan Healthcare Conference is rolling on Tuesday with [...]
Lyra Therapeutics is abandoning…
Lyra Therapeutics is abandoning work on its rhinosinusitis treatment and [...]
Gary Gibbons, M.D., is retiring as…
Gary Gibbons, M.D., is retiring as National Heart, Lung and [...]
A phase 3 rheumatoid arthritis…
A phase 3 rheumatoid arthritis trial of Lynk Pharmaceuticals’ JAK1 [...]
Teva has penned a second pact with…
Teva has penned a second pact with Royalty Pharma, this [...]
Eikon Therapeutics is planning to…
Eikon Therapeutics is planning to become the second biotech to [...]
The new year has ushered in a flow…
The new year has ushered in a flow of biotech-specific [...]
AirNexis Therapeutics is taking…
AirNexis Therapeutics is taking flight with $200 million and a [...]